<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606625/" ref="ordinalpos=466&amp;ncbi_uid=4736569&amp;link_uid=PMC3606625" image-link="/pmc/articles/PMC3606625/figure/F1/" class="imagepopup">Fig. 1. The EGFR <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> is of critical importance to human cancers and of a high complexity.  From: EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance. </a></div><br /><div class="p4l_captionBody">The EGFR signaling pathway exerts its biological effects via two major modes of actions, namely, the cytoplasmic/ traditional (<b>a</b>) and the nuclear (<b>b</b>) signaling modes.<b>a.</b> The cytoplasmic/traditional EGFR pathway is consisted of five major modules: PLC-Î³-CaMK/PKC, Ras-Raf-MAPK, PI-3K-Akt-mTOR, JAK2/STAT3 and STAT3. Activation of these signaling modules often leads to tumorigenesis, tumor proliferation, metastasis, chemoresistance, and radio-resistance.<b>b.</b> Nuclear EGFR has three key functions: (i) gene transactivation, (ii) tyrosine kinase, and (iii) protein-protein interaction.</div></div>